Basics Janux Therapeutics, Inc. IPO Date: June 11, 2021 Sector: Healthcare Industry: Biotech Market Cap: $937.1M Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 3.64% Avg Daily Range (30 D): $0.88 | 3.49% Avg Daily Range (90 D): $0.77 | 3.11% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): 1.8M Avg Daily Volume (90 D): 1.1M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,539 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $1.99M Avg Inst. Trade (90 D): $1.95M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.36M Avg Closing Trade (30 D): $2.61M Avg Closing Trade (90 D): $2.73M Avg Closing Volume: 96.78K     News Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research Apr 30, 2024 @ 12:50 PM Here's What Could Help Janux Therapeutics (JANX) M... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.67 $-.39 $-.55 Diluted EPS $-1.67 $-.39 $-.55 Revenue $ 10M $ 10M $ M Gross Profit $ $ $ Net Income / Loss $ -101.9M $ -24.31M $ -33.86M Operating Income / Loss $ -144.29M $ -35.25M $ -45.12M Cost of Revenue $ $ $ Net Cash Flow $ 21.64M $ -4.06M $ -21.3M PE Ratio